ISRCTN70791258已完成不适用
Treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy
Department of Nephrology, University Hospital in Lund (Sweden)0 个研究点目标入组 30 人开始时间: 2007年1月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Males and females
- •2. Age 18 to 90
- •3. Membranous nephropathy according to kidney biopsy
- •4. Proteinuria of the nephrotic range for at least six months
- •5. Treatment with a statin and an angiotensin converting enzyme inhibitor for at least three months
- •6. Urinary albumin excretion more than 3000 mg/24 hours
- •7. Serum albumin concentration less than 26 g/
排除标准
- •1. Moderate or heavy tubulointerstitial changes in the kidney biopsy
- •2. A recognisable cause of the nephrotic syndrome
- •3. Previous immunosuppressive treatment for the membranous nephropathy
- •4. Allergy to Synacthen Depot
- •5. Severe psychiatric disease
- •6. Pregnancy
- •7. History of noncompliance
研究者
相似试验
进行中（未招募）
不适用
Treatment with synthetic adrenocoticotropic hormone (ACTH) in patients with membranous nephropathy and high risk for renal failure. A pilot study. - ACTHiMeMembranous nephropathyMedDRA version: 9.1Level: LLTClassification code 10027170Term: Membranous nephropathyEUCTR2008-001647-19-NLRadboud University Nijmegen Medical Center
进行中（未招募）
1 期
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockSeptic ShockEUCTR2012-003158-10-IEThe George Institute for Global Health3,800
进行中（未招募）
1 期
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockSeptic ShockEUCTR2012-003158-10-DKThe George Institute for Global Health3,800
进行中（未招募）
不适用
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockMedDRA version: 16.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestationsSeptic ShockEUCTR2012-003158-10-GBThe George Institute for Global Health3,800
进行中（未招募）
1 期
Study of SPI-62 in Patients with Adrenocorticotropic Hormone-dependent Cushing’s SyndromeEUCTR2021-006184-19-BGSparrow Pharmaceuticals, Inc.26